Suicide in schizophrenia

References

• MacDonald AW, Schulz SC. What we know: findings that every theory of schizophrenia should explain. Schizophr. Bull.35, 493–508 (2009).
   PubMed Web of Science ®Google Scholar
• Dalman C, Thomas HV, David AS, Gentz J, Lewis G, Allebeck P. Signs of asphyxia at birth and risk of schizophrenia. Population-based case–control study. Br. J. Psychiatry179, 403–408 (2001).
   PubMed Web of Science ®Google Scholar
• Ichiki M, Kunugi H, Takei N et al. Intra-uterine physical growth in schizophrenia: evidence confirming excess of premature birth. Psychol. Med.30, 597–604 (2000).
   PubMed Web of Science ®Google Scholar
• Dalman C, Allebeck P. Paternal age and schizophrenia: further support for an association. Am. J. Psychiatry159, 1591–1592 (2002).
   PubMed Web of Science ®Google Scholar
• Bradbury TN, Miller GA. Season of birth in schizophrenia: a review of evidence, methodology, and etiology. Psychol. Bull.98, 569–594 (1985).
   PubMed Web of Science ®Google Scholar
• Barr CE, Mednick SA, Munk-Jorgensen P. Exposure to influenza epidemics during gestation and adult schizophrenia. A 40-year study. Arch. Gen. Psychiatry47, 869–874 (1990).
   PubMed Web of Science ®Google Scholar
• Dalman C, Allebeck P, Gunnell D et al. Infections in the CNS during childhood and the risk of subsequent psychotic illness: a cohort study of more than one million Swedish subjects. Am. J. Psychiatry165, 59–65 (2008).
   PubMed Web of Science ®Google Scholar
• McGrath J, Saha S, Welham J, El Saadi O, MacCauley C, Chant D. A systematic review of the incidence of schizophrenia: the distribution of rates and the influence of sex, urbanicity, migrant status and methodology. BMC Med.2, 13 (2004).
   PubMed Web of Science ®Google Scholar
• Sewell RA, Ranganathan M, D’Souza DC. Cannabinoids and psychosis. Int. Rev. Psychiatry21, 152–162 (2009).
   PubMed Web of Science ®Google Scholar
• McGrath J, Saha S, Chant D, Welham J. Schizophrenia: a concise overview of incidence, prevalence, and mortality. Epidemiol. Rev.30, 67–76 (2008).
   PubMed Web of Science ®Google Scholar
• Aleman A, Kahn RS, Selten JP. Sex differences in the risk of schizophrenia: evidence from meta-analysis. Arch. Gen. Psychiatry60, 565–571 (2003).
   PubMed Web of Science ®Google Scholar
• McGrath JJ. Variations in the incidence of schizophrenia: data versus dogma. Schizophr. Bull.32, 195–197 (2006).
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association (APA). Practice guideline for the assessment and treatment of patients with suicidal behaviors. Am. J. Psychiatry1–60 (2003).
   Web of Science ®Google Scholar
• Hawton K, van Heeringen K. Suicide. Lancet373, 1372–1381 (2009).
   PubMed Web of Science ®Google Scholar
• Hafner H. Gender differences in schizophrenia. Psychoneuroendocrinology28(Suppl. 2), 17–54 (2003).
   PubMed Web of Science ®Google Scholar
• Bleuler E. Dementia Praecox or the Group Schizophrenias. International University Press, NY, USA (1950).
   Google Scholar
• Baxter D, Appleby L. Case register study of suicide risk in mental disorders. Br. J. Psychiatry175, 322–326 (1999).
   PubMed Web of Science ®Google Scholar
• Caldwell CB, Gottesman II. Schizophrenics kill themselves too: a review of risk factors for suicide. Schizophr. Bull.16, 571–589 (1990).
   PubMed Web of Science ®Google Scholar
• Inskip HM, Harris EC, Barraclough B. Lifetime risk of suicide for affective disorder, alcoholism and schizophrenia. Br. J. Psychiatry172, 35–37 (1998).
   PubMed Web of Science ®Google Scholar
• Palmer BA, Pankratz VS, Bostwick JM. The lifetime risk of suicide in schizophrenia: a reexamination. Arch. Gen. Psychiatry62, 247–253 (2005).
   PubMed Web of Science ®Google Scholar
• Ösby U, Correia N, Brandt L, Ekbom A, Sparen P. Mortality and causes of death in schizophrenia in Stockholm county, Sweden. Schizophr. Res.45, 21–28 (2000).
   PubMed Web of Science ®Google Scholar
• Nordentoft M, Laursen TM, Agerbo E, Qin P, Hoyer EH, Mortensen PB. Change in suicide rates for patients with schizophrenia in Denmark, 1981–1997: nested case–control study. Br. Med. J.329, 261 (2004).
   PubMed Web of Science ®Google Scholar
• Saha S, Chant D, McGrath J. A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time? Arch. Gen. Psychiatry64, 1123–1131 (2007).
   PubMed Web of Science ®Google Scholar
• Mortensen PB, Juel K. Mortality and causes of death in first admitted schizophrenic patients. Br. J. Psychiatry163, 183–189 (1993).
   PubMed Web of Science ®Google Scholar
• Allebeck P, Varla A, Wistedt B. Suicide and violent death among patients with schizophrenia. Acta Psychiatr. Scand.74, 43–49 (1986).
   PubMed Web of Science ®Google Scholar
• Brown S. Excess mortality of schizophrenia. A meta-analysis. Br. J. Psychiatry171, 502–508 (1997).
   PubMed Web of Science ®Google Scholar
• Mann JJ, Waternaux C, Haas GL, Malone KM. Toward a clinical model of suicidal behavior in psychiatric patients. Am. J. Psychiatry156, 181–189 (1999).
   PubMed Web of Science ®Google Scholar
• Turecki G. Dissecting the suicide phenotype: the role of impulsive-aggressive behaviours. J. Psychiatry Neurosci.30, 398–408 (2005).
   PubMed Web of Science ®Google Scholar
• Mann JJ. Neurobiology of suicidal behaviour. Nat. Rev. Neurosci.4, 819–828 (2003).
   PubMed Web of Science ®Google Scholar
• Preston E, Hansen L. A systematic review of suicide rating scales in schizophrenia. Crisis26, 170–180 (2005).
   PubMedGoogle Scholar
• Radomsky ED, Haas GL, Mann JJ, Sweeney JA. Suicidal behavior in patients with schizophrenia and other psychotic disorders. Am. J. Psychiatry156, 1590–1595 (1999).
   PubMed Web of Science ®Google Scholar
• Kuo CJ, Tsai SY, Lo CH, Wang YP, Chen CC. Risk factors for completed suicide in schizophrenia. J. Clin. Psychiatry66, 579–585 (2005).
   PubMed Web of Science ®Google Scholar
• Alaräisänen A, Miettunen J, Rasanen P, Fenton W, Koivumaa-Honkanen HT, Isohanni M. Suicide rate in schizophrenia in the Northern Finland 1966 Birth Cohort. Soc. Psychiatry Psychiatr. Epidemiol.44, 1107–1110 (2009).
   PubMed Web of Science ®Google Scholar
• Hawton K, Sutton L, Haw C, Sinclair J, Deeks JJ. Schizophrenia and suicide: systematic review of risk factors. Br. J. Psychiatry187, 9–20 (2005).
   PubMed Web of Science ®Google Scholar
• Reutfors J, Brandt L, Jönsson EG, Ekbom A, Sparen P, Ösby U. Risk factors for suicide in schizophrenia: findings from a Swedish population-based case–control study. Schizophr. Res.108, 231–237 (2009).
   PubMed Web of Science ®Google Scholar
• Carlborg A, Jokinen J, Jönsson EG, Nordström AL, Nordström P. Long-term suicide risk in schizophrenia spectrum psychoses: survival analysis by gender. Arch. Suicide Res.12, 347–351 (2008).
   PubMed Web of Science ®Google Scholar
• Heilä H, Isometsä ET, Henriksson MM, Heikkinen ME, Marttunen MJ, Lönnqvist JK. Suicide and schizophrenia: a nationwide psychological autopsy study on age- and sex-specific clinical characteristics of 92 suicide victims with schizophrenia. Am. J. Psychiatry154, 1235–1242 (1997).
   PubMed Web of Science ®Google Scholar
• Qin P, Nordentoft M. Suicide risk in relation to psychiatric hospitalization: evidence based on longitudinal registers. Arch. Gen. Psychiatry62, 427–432 (2005).
   PubMed Web of Science ®Google Scholar
• Ho TP. The suicide risk of discharged psychiatric patients. J. Clin. Psychiatry64, 702–707 (2003).
   PubMed Web of Science ®Google Scholar
• Reutfors J, Brandt L, Ekbom A, Isacsson G, Sparen P, Ösby U. Suicide and hospitalization for mental disorders in Sweden: a population-based case–control study. J. Psychiatr. Res. DOI:10.1016/j.jpsychires.2010.02.003 (2010) (Epub ahead of print).
   PubMed Web of Science ®Google Scholar
• Roy A. Suicide in chronic schizophrenia. Br. J. Psychiatry141, 171–177 (1982).
   PubMed Web of Science ®Google Scholar
• Yarden PE. Observations on suicide in chronic schizophrenics. Compr. Psychiatry15, 325–333 (1974).
   PubMed Web of Science ®Google Scholar
• Lee HC, Lin HC. Are psychiatrist characteristics associated with postdischarge suicide of schizophrenia patients? Schizophr. Bull.35, 760–765 (2009).
   PubMed Web of Science ®Google Scholar
• Hansen V, Jacobsen BK, Arnesen E. Cause-specific mortality in psychiatric patients after deinstitutionalisation. Br. J. Psychiatry179, 438–443 (2001).
   PubMed Web of Science ®Google Scholar
• Seeman MV. An outcome measure in schizophrenia: mortality. Can. J. Psychiatry52, 55–60 (2007).
   PubMed Web of Science ®Google Scholar
• Pompili M, Amador XF, Girardi P et al. Suicide risk in schizophrenia: learning from the past to change the future. Ann. Gen. Psychiatry6, 10 (2007).
   PubMedGoogle Scholar
• Cavanagh JT, Carson AJ, Sharpe M, Lawrie SM. Psychological autopsy studies of suicide: a systematic review. Psychol. Med.33, 395–405 (2003).
   PubMed Web of Science ®Google Scholar
• Carlborg A, Jokinen J, Nordström AL, Jönsson EG, Nordström P. Attempted suicide predicts suicide risk in schizophrenia spectrum psychosis. Nord. J. Psychiatry64, 68–72 (2009).
   Web of Science ®Google Scholar
• Harris EC, Barraclough B. Suicide as an outcome for mental disorders. A meta-analysis. Br. J. Psychiatry170, 205–228 (1997).
   PubMed Web of Science ®Google Scholar
• Tidemalm D, Langström N, Lichtenstein P, Runeson B. Risk of suicide after suicide attempt according to coexisting psychiatric disorder: Swedish cohort study with long term follow-up. Br. Med. J.337, a2205 (2008).
   PubMed Web of Science ®Google Scholar
• Harkavy-Friedman JM, Restifo K, Malaspina D et al. Suicidal behavior in schizophrenia: characteristics of individuals who had and had not attempted suicide. Am. J. Psychiatry156, 1276–1278 (1999).
   PubMed Web of Science ®Google Scholar
• Hunt IM, Kapur N, Windfuhr K et al. Suicide in schizophrenia: findings from a national clinical survey. J. Psychiatr. Pract.12, 139–147 (2006).
   PubMedGoogle Scholar
• Gupta S, Black DW, Arndt S, Hubbard WC, Andreasen NC. Factors associated with suicide attempts among patients with schizophrenia. Psychiatric Services49, 1353–1355 (1998).
   PubMed Web of Science ®Google Scholar
• Roy A, Mazonson A, Pickar D. Attempted suicide in chronic schizophrenia. Br. J. Psychiatry144, 303–306 (1984).
   PubMed Web of Science ®Google Scholar
• Haw C, Hawton K, Sutton L, Sinclair J, Deeks J. Schizophrenia and deliberate self-harm: a systematic review of risk factors. Suicide Life Threat. Behav.35, 50–62 (2005).
   PubMed Web of Science ®Google Scholar
• Drake RE, Gates C, Cotton PG. Suicide among schizophrenics: a comparison of attempters and completed suicides. Br. J. Psychiatry149, 784–787 (1986).
   PubMed Web of Science ®Google Scholar
• Harkavy-Friedman JM, Nelson EA, Venarde DF, Mann JJ. Suicidal behavior in schizophrenia and schizoaffective disorder: examining the role of depression. Suicide Life Threat. Behav.34, 66–76 (2004).
   PubMed Web of Science ®Google Scholar
• Jones JS, Stein DJ, Stanley B, Guido JR, Winchel R, Stanley M. Negative and depressive symptoms in suicidal schizophrenics. Acta Psychiatr. Scand.89, 81–87 (1994).
   PubMed Web of Science ®Google Scholar
• Nordentoft M, Jeppesen P, Abel M et al. OPUS study: suicidal behaviour, suicidal ideation and hopelessness among patients with first-episode psychosis. One-year follow-up of a randomised controlled trial. Br. J. Psychiatry Suppl.43, S98–S106 (2002).
   Google Scholar
• Limosin F, Loze JY, Philippe A, Casadebaig F, Rouillon F. Ten-year prospective follow-up study of the mortality by suicide in schizophrenic patients. Schizophr. Res.94, 23–28 (2007).
   PubMed Web of Science ®Google Scholar
• Gut-Fayand A, Dervaux A, Olie JP, Loo H, Poirier MF, Krebs MO. Substance abuse and suicidality in schizophrenia: a common risk factor linked to impulsivity. Psychiatry Res.102, 65–72 (2001).
   PubMed Web of Science ®Google Scholar
• Barbee JG, Clark PD, Crapanzano MS, Heintz GC, Kehoe CE. Alcohol and substance abuse among schizophrenic patients presenting to an emergency psychiatric service. J. Nerv. Ment. Dis.177, 400–407 (1989).
   PubMed Web of Science ®Google Scholar
• Mauri MC, Volonteri LS, De Gaspari IF, Colasanti A, Brambilla MA, Cerruti L. Substance abuse in first-episode schizophrenic patients: a retrospective study. Clin. Pract. Epidemol. Ment. Health2, 4 (2006).
   PubMedGoogle Scholar
• Compton MT, Kelley ME, Ramsay CE et al. Association of pre-onset cannabis, alcohol, and tobacco use with age at onset of prodrome and age at onset of psychosis in first-episode patients. Am. J. Psychiatry166, 1251–1257 (2009).
   PubMed Web of Science ®Google Scholar
• Zammit S, Allebeck P, Andreasson S, Lundberg I, Lewis G. Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study. Br. Med. J.325, 1199 (2002).
   PubMed Web of Science ®Google Scholar
• Miller R, Ream G, McCormack J, Gunduz-Bruce H, Sevy S, Robinson D. A prospective study of cannabis use as a risk factor for non-adherence and treatment dropout in first-episode schizophrenia. Schizophr. Res.113, 138–144 (2009).
   PubMed Web of Science ®Google Scholar
• Cantwell R. Substance use and schizophrenia: effects on symptoms, social functioning and service use. Br. J. Psychiatry182, 324–329 (2003).
   PubMed Web of Science ®Google Scholar
• Zisook S, Heaton R, Moranville J, Kuck J, Jernigan T, Braff D. Past substance abuse and clinical course of schizophrenia. Am. J. Psychiatry149, 552–553 (1992).
   PubMed Web of Science ®Google Scholar
• Caton CL, Shrout PE, Eagle PF, Opler LA, Felix A, Dominguez B. Risk factors for homelessness among schizophrenic men: a case–control study. Am. J. Public Health84, 265–270 (1994).
   PubMed Web of Science ®Google Scholar
• Drake RE, Wallach MA, Teague GB, Freeman DH, Paskus TS, Clark TA. Housing instability and homelessness among rural schizophrenic patients. Am. J. Psychiatry148, 330–336 (1991).
   PubMed Web of Science ®Google Scholar
• Menezes PR, Johnson S, Thornicroft G et al. Drug and alcohol problems among individuals with severe mental illness in south London. Br. J. Psychiatry168, 612–619 (1996).
   PubMed Web of Science ®Google Scholar
• Duke PJ, Pantelis C, Barnes TR. South Westminster schizophrenia survey. Alcohol use and its relationship to symptoms, tardive dyskinesia and illness onset. Br. J. Psychiatry164, 630–636 (1994).
   PubMed Web of Science ®Google Scholar
• Scott H, Johnson S, Menezes P et al. Substance misuse and risk of aggression and offending among the severely mentally ill. Br. J. Psychiatry172, 345–350 (1998).
   PubMed Web of Science ®Google Scholar
• Fazel S, Grann M, Carlström E, Lichtenstein P, Långström N. Risk factors for violent crime in Schizophrenia: a national cohort study of 13,806 patients. J. Clin. Psychiatry70, 362–369 (2009).
   PubMed Web of Science ®Google Scholar
• Fazel S, Långström N, Hjern A, Grann M, Lichtenstein P. Schizophrenia, substance abuse, and violent crime. JAMA301, 2016–2023 (2009).
   PubMed Web of Science ®Google Scholar
• Fenton WS. Depression, suicide, and suicide prevention in schizophrenia. Suicide Life Threat. Behav.30, 34–49 (2000).
   PubMed Web of Science ®Google Scholar
• De Hert M, McKenzie K, Peuskens J. Risk factors for suicide in young people suffering from schizophrenia: a long-term follow-up study. Schizophr. Res.47, 127–134 (2001).
   PubMed Web of Science ®Google Scholar
• Drake RE, Gates C, Cotton PG, Whitaker A. Suicide among schizophrenics. Who is at risk? J. Nerv. Ment. Dis.172, 613–617 (1984).
   PubMed Web of Science ®Google Scholar
• Alaräisänen A, Miettunen J, Lauronen E, Rasanen P, Isohanni M. Good school performance is a risk factor of suicide in psychoses: a 35-year follow up of the Northern Finland 1966 Birth Cohort. Acta Psychiatr. Scand.114, 357–362 (2006).
   PubMed Web of Science ®Google Scholar
• Montross LP, Zisook S, Kasckow J. Suicide among patients with schizophrenia: a consideration of risk and protective factors. Ann. Clin. Psychiatry17, 173–182 (2005).
   PubMedGoogle Scholar
• Bourgeois M, Swendsen J, Young F et al. Awareness of disorder and suicide risk in the treatment of schizophrenia: results of the international suicide prevention trial. Am. J. Psychiatry161, 1494–1496 (2004).
   PubMed Web of Science ®Google Scholar
• Kim CH, Jayathilake K, Meltzer HY. Hopelessness, neurocognitive function, and insight in schizophrenia: relationship to suicidal behavior. Schizophr. Res.60, 71–80 (2003).
   PubMed Web of Science ®Google Scholar
• Leucht S, Heres S. Epidemiology, clinical consequences, and psychosocial treatment of nonadherence in schizophrenia. J. Clin. Psychiatry67(Suppl. 5), 3–8 (2006).
   PubMed Web of Science ®Google Scholar
• Novick D, Haro JM, Suarez D, Perez V, Dittmann RW, Haddad PM. Predictors and clinical consequences of non-adherence with antipsychotic medication in the outpatient treatment of schizophrenia. Psychiatry Res.176(2–3), 109–113 (2010).
   PubMed Web of Science ®Google Scholar
• Haukka J, Tiihonen J, Härkänen T, Lönnqvist J. Association between medication and risk of suicide, attempted suicide and death in nationwide cohort of suicidal patients with schizophrenia. Pharmacoepidemiol. Drug Saf.17, 686–696 (2008).
   PubMed Web of Science ®Google Scholar
• Pompili M, Lester D, Innamorati M, Tatarelli R, Girardi P. Assessment and treatment of suicide risk in schizophrenia. Expert Rev. Neurother.8, 51–74 (2008).
   PubMedGoogle Scholar
• Taiminen TJ, Kujari H. Antipsychotic medication and suicide risk among schizophrenic and paranoid inpatients. A controlled retrospective study. Acta Psychiatr. Scand.90, 247–251 (1994).
   PubMed Web of Science ®Google Scholar
• Lester D. Sex differences in completed suicide by schizophrenic patients: a meta-analysis. Suicide Life Threat. Behav.36, 50–56 (2006).
   PubMed Web of Science ®Google Scholar
• Canetto SS. Women and suicidal behavior: a cultural analysis. Am. J. Orthopsychiatry78, 259–266 (2008).
   PubMed Web of Science ®Google Scholar
• Liu KY, Chen EY, Cheung AS, Yip PS. Psychiatric history modifies the gender ratio of suicide: an East and West comparison. Soc. Psychiatry Psychiatr. Epidemiol.44, 130–134 (2009).
   PubMed Web of Science ®Google Scholar
• Yip PS, Callanan C, Yuen HP. Urban/rural and gender differentials in suicide rates: east and west. J. Affect. Disord.57, 99–106 (2000).
   PubMed Web of Science ®Google Scholar
• von Borczyskowski A, Lindblad F, Vinnerljung B, Hjern A. Gender differences in risk factors for suicide: findings from a Swedish national cohort study. Can. J. Psychiatry55(2), 108–111 (2009).
   Web of Science ®Google Scholar
• Karvonen K, Sammela HL, Rahikkala H et al. Sex, timing, and depression among suicide victims with schizophrenia. Compr. Psychiatry48, 319–322 (2007).
   PubMed Web of Science ®Google Scholar
• Salokangas RK. Prognostic implications of the sex of schizophrenic patients. Br. J. Psychiatry142, 145–151 (1983).
   PubMed Web of Science ®Google Scholar
• Seeman MV. Suicide among women with schizophrenia spectrum disorders. J. Psychiatr. Pract.15, 235–242 (2009).
   PubMed Web of Science ®Google Scholar
• Goodwin R, Lyons JS, McNally RJ. Panic attacks in schizophrenia. Schizophr. Res.58, 213–220 (2002).
   PubMed Web of Science ®Google Scholar
• Hu WH, Sun CM, Lee CT, Peng SL, Lin SK, Shen WW. A clinical study of schizophrenic suicides. 42 cases in Taiwan. Schizophr. Res.5, 43–50 (1991).
   PubMed Web of Science ®Google Scholar
• Baca-Garcia E, Perez-Rodriguez MM, Diaz Sastre C, Saiz-Ruiz J, de Leon J. Suicidal behavior in schizophrenia and depression: a comparison. Schizophr. Res.75, 77–81 (2005).
   PubMed Web of Science ®Google Scholar
• Mann JJ, Currier D, Stanley B, Oquendo MA, Amsel LV, Ellis SP. Can biological tests assist prediction of suicide in mood disorders? Int. J. Neuropsychopharmacol.9, 465–474 (2006).
   PubMed Web of Science ®Google Scholar
• Nordström P, Samuelsson M, Åsberg M et al. CSF 5-HIAA predicts suicide risk after attempted suicide. Suicide Life Threat. Behav.24, 1–9 (1994).
   PubMed Web of Science ®Google Scholar
• Åsberg M. Neurotransmitters and suicidal behavior. The evidence from cerebrospinal fluid studies. Ann. NY Acad. Sci.836, 158–181 (1997).
   PubMed Web of Science ®Google Scholar
• Lester D. The concentration of neurotransmitter metabolites in the cerebrospinal fluid of suicidal individuals: a meta-analysis. Pharmacopsychiatry28, 45–50 (1995).
   PubMed Web of Science ®Google Scholar
• Engström G, Alling C, Blennow K, Regnell G, Träskman-Bendz L. Reduced cerebrospinal HVA concentrations and HVA/5-HIAA ratios in suicide attempters. Monoamine metabolites in 120 suicide attempters and 47 controls. Eur. Neuropsychopharmacol.9, 399–405 (1999).
   PubMed Web of Science ®Google Scholar
• Jokinen J, Nordström AL, Nordström P. The relationship between CSF HVA/5-HIAA ratio and suicide intent in suicide attempters. Arch. Suicide Res.11, 187–192 (2007).
   PubMed Web of Science ®Google Scholar
• Roy A, Ågren H, Pickar D et al. Reduced CSF concentrations of homovanillic acid and homovanillic acid to 5-hydroxyindoleacetic acid ratios in depressed patients: relationship to suicidal behavior and dexamethasone nonsuppression. Am. J. Psychiatry143, 1539–1545 (1986).
   PubMed Web of Science ®Google Scholar
• Mann JJ, Malone KM, Psych MR et al. Attempted suicide characteristics and cerebrospinal fluid amine metabolites in depressed inpatients. Neuropsychopharmacology15, 576–586 (1996).
   PubMed Web of Science ®Google Scholar
• Träskman-Bendz L, Alling C, Oreland L, Regnell G, Vinge E, Öhman R. Prediction of suicidal behavior from biologic tests. J. Clin. Psychopharmacol.12, S21–S26 (1992).
   Google Scholar
• Placidi GP, Oquendo MA, Malone KM, Huang YY, Ellis SP, Mann JJ. Aggressivity, suicide attempts, and depression: relationship to cerebrospinal fluid monoamine metabolite levels. Biol. Psychiatry50, 783–791 (2001).
   PubMed Web of Science ®Google Scholar
• Carlborg A, Jokinen J, Nordström AL, Jönsson EG, Nordström P. CSF 5-HIAA, attempted suicide and suicide risk in schizophrenia spectrum psychosis. Schizophr. Res.112, 80–85 (2009).
   PubMed Web of Science ®Google Scholar
• Marcinko D, Pivac N, Martinac M, Jakovljevic M, Mihaljevic-Peles A, Muck-Seler D. Platelet serotonin and serum cholesterol concentrations in suicidal and non-suicidal male patients with a first episode of psychosis. Psychiatry Res.150, 105–108 (2007).
   PubMed Web of Science ®Google Scholar
• Jokinen J, Carlborg A, Mårtensson B, Forslund K, Nordström AL, Nordström P. DST non-suppression predicts suicide after attempted suicide. Psychiatry Res.150, 297–303 (2007).
   PubMed Web of Science ®Google Scholar
• Plocka-Lewandowska M, Araszkiewicz A, Rybakowski JK. Dexamethasone suppression test and suicide attempts in schizophrenic patients. Eur. Psychiatry16, 428–431 (2001).
   PubMed Web of Science ®Google Scholar
• Lewis CF, Tandon R, Shipley JE et al. Biological predictors of suicidality in schizophrenia. Acta Psychiatr. Scand.94, 416–420 (1996).
   PubMed Web of Science ®Google Scholar
• Pickar D, Roy A, Breier A et al. Suicide and aggression in schizophrenia. Neurobiologic correlates. Ann. NY Acad. Sci.487, 189–196 (1986).
   PubMedGoogle Scholar
• Baldessarini RJ, Hennen J. Genetics of suicide: an overview. Harv. Rev. Psychiatry12, 1–13 (2004).
   PubMed Web of Science ®Google Scholar
• Courtet P, Jollant F, Castelnau D, Buresi C, Malafosse A. Suicidal behavior: relationship between phenotype and serotonergic genotype. Am. J. Med. Genet. C Semin. Med. Genet.133C, 25–33 (2005).
   PubMed Web of Science ®Google Scholar
• Qin P, Agerbo E, Mortensen PB. Suicide risk in relation to family history of completed suicide and psychiatric disorders: a nested case–control study based on longitudinal registers. Lancet360, 1126–1130 (2002).
   PubMed Web of Science ®Google Scholar
• Runeson B, Åsberg M. Family history of suicide among suicide victims. Am. J. Psychiatry160, 1525–1526 (2003).
   PubMed Web of Science ®Google Scholar
• Li D, He L. Meta-analysis supports association between serotonin transporter (5-HTT) and suicidal behavior. Mol. Psychiatry12, 47–54 (2007).
   PubMed Web of Science ®Google Scholar
• Li D, Duan Y, He L. Association study of serotonin 2A receptor (5-HT2A) gene with schizophrenia and suicidal behavior using systematic meta-analysis. Biochem. Biophys. Res. Commun.340, 1006–1015 (2006).
   PubMed Web of Science ®Google Scholar
• Saetre P, Lundmark P, Wang A et al. The tryptophan hydroxylase 1 (TPH1) gene, schizophrenia susceptibility, and suicidal behavior: A multi-centre case–control study and meta-analysis. Am. J. Med. Genet. B Neuropsychiatr. Genet.153B, 387–396 (2010).
   PubMed Web of Science ®Google Scholar
• Fanous AH, Chen X, Wang X et al. Genetic variation in the serotonin 2A receptor and suicidal ideation in a sample of 270 Irish high-density schizophrenia families. Am. J. Med. Genet. B Neuropsychiatr. Genet.150B, 411–417 (2009).
   PubMed Web of Science ®Google Scholar
• De Luca V, Tharmalingam S, Zai C et al. Association of HPA axis genes with suicidal behaviour in schizophrenia. J. Psychopharmacol.24(5), 677–682 (2010).
   PubMed Web of Science ®Google Scholar
• Feldcamp LA, Souza RP, Romano-Silva M, Kennedy JL, Wong AH. Reduced prefrontal cortex DARPP-32 mRNA in completed suicide victims with schizophrenia. Schizophr. Res.103, 192–200 (2008).
   PubMed Web of Science ®Google Scholar
• Wasserman D, Terenius L, Wasserman J, Sokolowski M. The 2009 Nobel conference on the role of genetics in promoting suicide prevention and the mental health of the population. Mol. Psychiatry15, 12–17 (2010).
   PubMed Web of Science ®Google Scholar
• Aguilar EJ, Garcia-Marti G, Marti-Bonmati L et al. Left orbitofrontal and superior temporal gyrus structural changes associated to suicidal behavior in patients with schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry32, 1673–1676 (2008).
   PubMed Web of Science ®Google Scholar
• Rusch N, Spoletini I, Wilke M et al. Inferior frontal white matter volume and suicidality in schizophrenia. Psychiatry Res.164, 206–214 (2008).
   PubMed Web of Science ®Google Scholar
• Maris RW, Berman A, Silverman MM. Treatment and prevention of suicide. In: Comprehensive Textbook of Suicidology. Maris RW, Berman A, Silverman MM (Eds). Guilford Press, NY, USA (2000).
   Google Scholar
• Nordentoft M. Prevention of suicide and attempted suicide in Denmark. Epidemiological studies of suicide and intervention studies in selected risk groups. Dan. Med. Bull.54, 306–369 (2007).
   PubMed Web of Science ®Google Scholar
• Mann JJ, Apter A, Bertolote J et al. Suicide prevention strategies: a systematic review. JAMA294, 2064–2074 (2005).
   PubMed Web of Science ®Google Scholar
• Melle I, Johannesen JO, Friis S et al. Early detection of the first episode of schizophrenia and suicidal behavior. Am. J. Psychiatry163, 800–804 (2006).
   PubMed Web of Science ®Google Scholar
• Tiihonen J, Lönnqvist J, Wahlbeck K et al. 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study). Lancet374, 620–627 (2009).
   PubMed Web of Science ®Google Scholar
• Altamura AC, Anand R, Bertoldi A et al. Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT). Arch. Gen. Psychiatry60, 82–91 (2003).
   PubMed Web of Science ®Google Scholar
• Hennen J, Baldessarini RJ. Suicidal risk during treatment with clozapine: a meta-analysis. Schizophr. Res.73, 139–145 (2005).
   PubMed Web of Science ®Google Scholar
• De Hert M, Correll CU, Cohen D. Do antipsychotic medications reduce or increase mortality in schizophrenia? A critical appraisal of the FIN-11 study. Schizophr. Res.117, 68–74 (2010).
   PubMed Web of Science ®Google Scholar
• Cipriani A, Pretty H, Hawton K, Geddes JR. Lithium in the prevention of suicidal behavior and all-cause mortality in patients with mood disorders: a systematic review of randomized trials. Am. J. Psychiatry162, 1805–1819 (2005).
   PubMed Web of Science ®Google Scholar
• Leucht S, McGrath J, Kissling W. Lithium for schizophrenia. Cochrane Database Syst. Rev.3, CD003834 (2003).
   Google Scholar
• Sharma V. The effect of electroconvulsive therapy on suicide risk in patients with mood disorders. Can. J. Psychiatry46, 704–709 (2001).
   PubMed Web of Science ®Google Scholar
• Prudic J, Sackeim HA. Electroconvulsive therapy and suicide risk. J. Clin. Psychiatry60(Suppl. 2), 104–110; discussion 111–106 (1999).
   PubMed Web of Science ®Google Scholar
• Popeo DM. Electroconvulsive therapy for depressive episodes: a brief review. Geriatrics64, 9–12 (2009).
   PubMed Web of Science ®Google Scholar
• Henriksson S, Isacsson G. Increased antidepressant use and fewer suicides in Jämtland county, Sweden, after a primary care educational programme on the treatment of depression. Acta Psychiatr. Scand.114, 159–167 (2006).
   PubMed Web of Science ®Google Scholar
• Isacsson G, Rich CL. Antidepressant drug use and suicide prevention. Int. Rev. Psychiatry17, 153–162 (2005).
   PubMed Web of Science ®Google Scholar
• Alaräisänen A, Heikkinen J, Kianickova Z, Miettunen J, Räsänen P, Isohanni M. Pathways leading to suicide in schizophrenia. Curr. Psych. Rev.3, 233–242 (2007).
   Google Scholar
• Meltzer H, Conley R, De Leo D et al. Intervention strategies for suicidality. J. Clin. Psychiatry Audiograph Series6, 1–18 (2003).
   Google Scholar
• Bateman K, Hansen L, Turkington D, Kingdon D. Cognitive behavioral therapy reduces suicidal ideation in schizophrenia: results from a randomized controlled trial. Suicide Life Threat. Behav.37, 284–290 (2007).
   PubMed Web of Science ®Google Scholar
• Rossau CD, Mortensen PB. Risk factors for suicide in patients with schizophrenia: nested case–control study. Br. J. Psychiatry171, 355–359 (1997).
   PubMed Web of Science ®Google Scholar
• De Leo D, Spathonis K. Do psychosocial and pharmacological interventions reduce sucide in schizophrenia and schizophrenia spectrum disorders? Arch. Suicide Res.7(4), 353–374 (2003).
   Google Scholar
• Acosta FJ, Aguilar EJ, Cejas MR, Gracia R, Caballero-Hidalgo A, Siris SG. Are there subtypes of suicidal schizophrenia? A prospective study. Schizophr. Res.86, 215–220 (2006).
   PubMed Web of Science ®Google Scholar
• Skegg K. Self-harm. Lancet366, 1471–1483 (2005).
   PubMed Web of Science ®Google Scholar